SG14795G - Process for transforming a human insulin precursor to human insulin - Google Patents

Process for transforming a human insulin precursor to human insulin

Info

Publication number
SG14795G
SG14795G SG14795A SG14795A SG14795G SG 14795 G SG14795 G SG 14795G SG 14795 A SG14795 A SG 14795A SG 14795 A SG14795 A SG 14795A SG 14795 G SG14795 G SG 14795G
Authority
SG
Singapore
Prior art keywords
human insulin
transforming
precursor
insulin precursor
human
Prior art date
Application number
SG14795A
Other languages
English (en)
Inventor
Bruce Hill Frank
Richard Eugene Heiney
Walter Francis Prouty
Mark Robert Walden
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to SG14795A priority Critical patent/SG14795G/en
Publication of SG14795G publication Critical patent/SG14795G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG14795A 1986-10-14 1995-01-27 Process for transforming a human insulin precursor to human insulin SG14795G (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG14795A SG14795G (en) 1986-10-14 1995-01-27 Process for transforming a human insulin precursor to human insulin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91793986A 1986-10-14 1986-10-14
SG14795A SG14795G (en) 1986-10-14 1995-01-27 Process for transforming a human insulin precursor to human insulin

Publications (1)

Publication Number Publication Date
SG14795G true SG14795G (en) 1995-06-16

Family

ID=25439543

Family Applications (1)

Application Number Title Priority Date Filing Date
SG14795A SG14795G (en) 1986-10-14 1995-01-27 Process for transforming a human insulin precursor to human insulin

Country Status (26)

Country Link
US (1) US5457066A (xx)
EP (1) EP0264250B1 (xx)
JP (1) JP2634176B2 (xx)
KR (1) KR970003519B1 (xx)
CN (1) CN1029131C (xx)
AR (1) AR243608A1 (xx)
AT (1) ATE115962T1 (xx)
AU (1) AU595934B2 (xx)
CA (1) CA1339955C (xx)
CY (1) CY1830A (xx)
DE (1) DE3750897T2 (xx)
DK (1) DK175266B1 (xx)
EG (1) EG18520A (xx)
ES (1) ES2065321T3 (xx)
GR (1) GR3015143T3 (xx)
HK (1) HK39495A (xx)
HU (1) HU204572B (xx)
IE (1) IE65972B1 (xx)
IL (1) IL84110A (xx)
MX (1) MX168305B (xx)
NZ (1) NZ222082A (xx)
PH (1) PH26471A (xx)
PT (1) PT85892B (xx)
RU (1) RU1829939C (xx)
SG (1) SG14795G (xx)
ZA (1) ZA877505B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130236A (en) * 1989-12-07 1992-07-14 Eli Lilly And Company Process for producing des(64,65)-proinsulin
FI103805B (fi) 1990-09-05 1999-09-30 Hoechst Ag Menetelmä preproinsuliinien hydroloimiseksi
CZ342492A3 (en) * 1991-11-26 1993-06-16 Lilly Co Eli Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised
CA2102673A1 (en) * 1992-11-13 1994-05-14 Michael G. Greaney Expression vectors for bovine trypsin and trypsinogen and host cells transformed therewith
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
US6087558A (en) * 1998-07-22 2000-07-11 Prodigene, Inc. Commercial production of proteases in plants
CA2328614C (en) 1999-02-12 2012-06-26 Biostream, Inc. Matrices for drug delivery and methods for making and using the same
US7169889B1 (en) 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US20020164712A1 (en) * 2000-12-11 2002-11-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence
EP1346726A4 (en) * 2000-12-25 2004-09-15 Shiseido Co Ltd FRAGRANCE COMPOSITION STIMULATING THE SYMPATHETIC SYSTEM
US7060675B2 (en) 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7312192B2 (en) 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7166571B2 (en) 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6913903B2 (en) 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
KR100925381B1 (ko) * 2001-11-19 2009-11-09 노보 노르디스크 에이/에스 인슐린 화합물의 제조 방법
EP1572720A4 (en) * 2002-05-24 2008-12-24 Nps Allelix Corp PROCESS FOR THE ENZYMATIC PRODUCTION OF GLP-2 (1-34) AND GLP-2 (1-33) PEPTIDES
DE60334912D1 (de) * 2002-05-24 2010-12-23 Medtronic Inc Polypeptid-spaltungsprozess
WO2003099853A2 (en) * 2002-05-24 2003-12-04 Restoragen, Inc. Petide amidation process
WO2003105768A2 (en) * 2002-06-13 2003-12-24 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
DE10235168A1 (de) 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
EP1704234B1 (en) * 2003-11-21 2012-01-18 NPS Pharmaceuticals, Inc. Production of glucagon like peptide 2 and analogs
DE602004025192D1 (de) * 2003-12-05 2010-03-11 Roche Diagnostics Gmbh Rekombinante Carboxypeptidase B und ihre Aufreinigung
EP2626368B1 (en) 2004-07-19 2016-12-21 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
BRPI0818004B8 (pt) 2007-10-16 2021-05-25 Biocon Ltd composição farmacêutica sólida administrável por via oral e o processo da mesma.
BRPI0823004B8 (pt) * 2008-08-07 2021-05-25 Biocon Ltd processo para preparação de compostos de insulina
WO2012104099A1 (en) * 2011-02-04 2012-08-09 Glucometrix Ag Process for the production of recombinant trypsin
WO2012115640A1 (en) 2011-02-23 2012-08-30 Elona Biotechnologies Liquid insulin- containing compositions and methods of making the same
JP2018531007A (ja) * 2015-09-24 2018-10-25 ハンミ ファーマシューティカル カンパニー リミテッド インスリンの製造方法
KR20200080747A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 인슐린 전구체의 인슐린 효소 전환용 조성물 및 이를 이용하여 인슐린 전구체를 인슐린으로 전환하는 방법
WO2023225534A1 (en) 2022-05-18 2023-11-23 Protomer Technologies Inc. Aromatic boron-containing compounds and related insulin analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5756878A (en) * 1980-09-22 1982-04-05 Sharp Corp Cleaning device
DK149824C (da) * 1982-01-22 1987-03-16 Carlsberg Biotechnology Ltd Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyrer i insuliner

Also Published As

Publication number Publication date
EG18520A (en) 1993-04-30
US5457066A (en) 1995-10-10
DK175266B1 (da) 2004-08-02
PT85892A (en) 1987-11-01
AU7952887A (en) 1988-04-21
EP0264250A2 (en) 1988-04-20
CA1339955C (en) 1998-07-14
CN1029131C (zh) 1995-06-28
ES2065321T3 (es) 1995-02-16
JP2634176B2 (ja) 1997-07-23
HK39495A (en) 1995-03-24
PT85892B (pt) 1990-07-31
CY1830A (en) 1995-12-01
HU204572B (en) 1992-01-28
NZ222082A (en) 1989-08-29
KR880005262A (ko) 1988-06-28
EP0264250A3 (en) 1990-03-21
AR243608A1 (es) 1993-08-31
ATE115962T1 (de) 1995-01-15
MX168305B (es) 1993-05-17
JPS63105695A (ja) 1988-05-10
DE3750897T2 (de) 1995-05-18
PH26471A (en) 1992-07-27
DE3750897D1 (de) 1995-02-02
HUT46363A (en) 1988-10-28
DK528487D0 (da) 1987-10-09
IE65972B1 (en) 1995-11-29
GR3015143T3 (en) 1995-05-31
IE872743L (en) 1988-04-14
IL84110A0 (en) 1988-03-31
RU1829939C (ru) 1993-07-23
AU595934B2 (en) 1990-04-12
DK528487A (da) 1988-04-15
IL84110A (en) 1992-11-15
KR970003519B1 (ko) 1997-03-18
EP0264250B1 (en) 1994-12-21
CN87107019A (zh) 1988-04-27
ZA877505B (en) 1989-05-30

Similar Documents

Publication Publication Date Title
EG18520A (en) Process for transforming a human insulin precursor to human insulin
HUT43821A (en) Process for producing amlodipine-benzenesulfonate
HUT48225A (en) Process for producing 2-chloro-5-chloromethylthiazole
HUT47279A (en) Process for producing pyridazodiazepines
HUT46304A (en) Process for producing 3-pyrrolidinoles
HUT49293A (en) Process for producing curative preparation
ZA868600B (en) An optically pure compound and a process for its preparation
EP0261627A3 (en) Process for producing l-arginine
AU5514586A (en) A process for producing human growth hormone
AR244242A1 (es) Un procedimiento para producir proinsulina humana cristalina.
GB2179042B (en) A process of producing ginsenoside-rd
DE3760336D1 (en) Process for producing a carbon fiber precursor
HUT47294A (en) Process for producing pyridobenzoxadiazines
EP0473205A3 (en) Process for producing a medical tube
DE3665571D1 (en) A continuous process for producing 5-vinyl-2-norbornene
PT85372A (en) Bisucaderin a process for producing this compound and its use as a medicament
HUT52039A (en) Process for transforming pyretroide isomeres to a more active form
AU6942387A (en) A method to treat blood
HUT44080A (en) Process for producing l-lysin
IL84403A (en) Process for the preparation of a nitrobenzoylalkane-sulfonamide
GB2197351B (en) Knitted structure and a process for its production
ZA872401B (en) Process for preparing a filter body
HUT44008A (en) Process for producing n-sulfonylmethyl-formamides
EP0219295A3 (en) Process for producing human growth hormone
HUT45519A (en) Process for producing naphthothiazocinones